Business
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa
TNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa.
About this update from Biostax Corp.
[{"type":"text","content":"\n\n\n\nTNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nTNI BioTech, Inc. Signs Non-Exclusive Distribution Agreement for Lodonal™ for Cancer and Receives First Sale in Africa\nPR Newswire\nORLANDO, Fla. and DUBLIN, June 25, 2014\n\n\n\nORLANDO, Fla. and DUBLIN, June 25, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC-TNIB) (\"TNI BioTech\") is pleased to announce that its pharmaceutical sales division, Airmed Biopharma Limited, (\"Airmed\"), a wholly owned Irish Company, has signed a non-exclusive distribution agreement with PanAm Global Logistics, Inc. (\"PanAm\") to market Lodonal™.\n\nTNI BioTech had received approval for Lodonal™ from the Republic of Malawi and with that approval Airmed has signed a distribution agreement with PanAm for Lodonal™ for sales through its distributor network to hospitals, pharmacists and doctors in Malawi.  The Company has received an initial purchase order for $150,000 and by the agreement, PanAm seeks to distribute a minimum of 5,000 pills per month for the balance of the year with sales expected to increase in 2015.  TNI BioTech and Airmed will deliver the first shipment by July 7, 2014.  TNI BioTech and Airmed estimate that the agreement will generate approximately $1,800,000 in revenue in year one of the distribution relationship. \n\n\"During our negotiations and due diligence phase, we were impressed by the quality standards of manufacture demonstrated by TNI BioTech and extensive medical research and intellectual property supporting its claims for Lodonal™ as well as the servicing capacity of Airmed.  We look forward to a long and successful business arrangement and we anticipate strong and increasing demand for Lodonal™ from our national and international distribution partners,\" said Andres Rodriguez, Operations Manager for PanAm.\n\nThe distributor relationship was secured through the efforts of His Excellency Ambassador Jack Brewer, founder and CEO...